LOUMEAU ERIC J

Chief Legal Officer sells 10,000 ANAB shares at $54.00; stock now $53.08, near 52-week high of $55.25

LOUMEAU ERIC J sold 10,000 shares (43.8% reduction from 22,835 to 12,835 shares held) at $54.00 on 2026-02-11, for $540,000.00 total value. The stock is currently trading at $53.08, only -3.9% from its 52-week high of $55.25, and has appreciated 57.0% over the past 90 days and 5.6% over 30 days. His prior five sales at this ticker have been mixed: three showed negative 30-day returns (-8.5%, -2.8%, -0.7%) and two showed positive returns (+3.7%, +2.4%), with no measurable 90-day outcomes yet available for any of these December 2025 transactions. The company posted strong recent fundamentals (Q4 revenue $76.3M, net income $15.1M, 432.0% annual revenue growth), though it was unprofitable over its most recent full fiscal year. The sale reduces the insider's stake meaningfully but at a price near recent highs in a strong uptrend.

ANAB Chief Legal Officer sells 10,000 shares at $51.00; stock up 126.0% in 90 days post-transaction completion pattern of 4 sales in 4 trading days

Eric J. Loumeau, Chief Legal Officer, sold 10,000 shares at $51.00 on 2025-12-22, reducing his holdings from 18,947 to 8,947 shares (52.8% reduction). This sale occurred as part of a concentrated pattern: the same insider sold on 2025-12-18, 2025-12-17, and twice on 2025-12-16, indicating four separate dispositions within a single trading week. The stock has appreciated significantly since the December transaction dates, with a 126.0% 90-day change and 30-day change of +26.3%, currently trading near its 52-week high of $50.33. While the company shows strong recent fundamentals—$76.3M in latest quarterly revenue, $15.1M net income, and +432.0% annual revenue growth—the rapid, consecutive nature of these insider sales across multiple trading days warrants investor attention to understand whether these transactions reflect a prearranged schedule, available liquidity needs, or other material factors.

Chief Legal Officer Eric Loumeau sold 22,641 shares for $1,027,425.25, reducing holdings by 71.7% across 4 transactions (12/16–12/18)

Eric Loumeau, Chief Legal Officer of AnaptysBio, executed 4 separate sales totaling 22,641 shares for $1,027,425.25 between December 16 and 18, 2025, at blended average price $45.38, reducing his post-transaction holdings to 8,947 shares from 31,588 shares (a 71.7% reduction). The transaction occurred as the stock near its 52-week high of $47.53 and after a 28.4% 30-day and 128.1% 90-day price surge. While the company shows strong recent results—$76.3M quarterly revenue, +432.0% annual growth, $15.1M net income in latest quarter—it was unprofitable on a full-year basis, indicating recent-quarter profitability may be a near-term inflection rather than sustained performance. The magnitude and timing of this sale, divesting over 70% of holdings at a share price within 0.1% of the 52-week peak, warrants attention to whether this reflects executive confidence in current valuation or other considerations.